LEADERSHIP & Advisors

OVERVIEW

Avara is led by a team of experienced, entrepreneurial industry leaders with proven backgrounds in pharmaceutical manufacturing, healthcare, and technical services.

Avara Pharmaceutical Services is an affiliate of the American Industrial Acquisition Corporation (www.aiac.com).

Larry P. Lee

Chief Executive Officer

Larry P. Lee is the CEO of Avara Pharmaceutical Services. He is a proven leader with over 25 years of experience in the pharmaceutical industry. He is actively involved in system integrations as well as creating added value across our sites and continents. He has a strong focus on operational excellence within all facets of solid dose manufacturing and packaging capabilities.

Larry has a unique ability to combine a successful company culture with proven business results. He has the responsibility for Avara’s global manufacturing facilities, and he will continue to lead our Norman Oklahoma Global Headquarters for Avara Pharmaceutical Services.

Larry has held various management positions in the laboratories, quality assurance, and information technologies in the pharmaceutical manufacturing space. He has been heavily involved in leading global initiatives for multiple pharmaceutical companies, including Avara. He is skilled at managing complex teams under the regulatory authority of Europe, Japan, and the United States.

Larry is a highly regarded member of the Avara Executive Committee. He has earned the respect and trust from his colleagues around the world through his professional approach, extensive knowledge, and a genuine desire to meet customer needs.

Larry holds a Bachelor of Science degree in Biological Sciences from Oklahoma State University.

Andy Glanville

Executive Vice President, Chief Financial Officer

Andy K. Glanville has more than 20 years of experience in Finance and Financial Management with his last 14 years focused in the Pharmaceutical Industry. Andy is a Chartered Institute of Management Accounts (CIMA) Qualified Manager with experience managing all aspects in the finance function, including ERP systems, manufacturing planning, budgeting as well as costing and reporting accounting in a US / Swiss GAAP environment. Andy has gained specialized expertise in manufacturing accounting, cost control, production planning / forecasting, capacity planning, standard costing, financial modelling, inventory control and cash management.

Since joining Avara’s Corporate Executive Committee as our EVP and CFO in January 2019, Andy is responsible for the financial strength of Avara Pharmaceutical Service. He works closely with the Commercial and Business Development Teams to identify and finance new project opportunities for our global sites that positions Avara for maximum profit, sustainability and growth. In addition, Andy in an integral part of the Pricing Committee that reviews and presents viable new project opportunities to the EC and managing board of AIAC for approval and capital investment.

Andy began his career with ICN and Valeant Pharmaceuticals as a finance leader in global manufacturing and the finance controller. In 2007 he assumed the role of the finance lead with Novartis Consumer Healthcare for a manufacturing network re-design project. Prior to his appointment as the EVP and CFO for Avara, Andy held financial leadership roles with Covidien Pharmaceuticals in the USA and Legacy Pharmaceuticals in Switzerland.

Andy holds a B.Comm.Acc (Hons), Economics, Law, Accountancy from The University of Birmingham, UK.

William Pasek

Executive Vice President, Chief Commercial Officer

Bill Pasek has over 25 years of experience in sales leadership roles. He served as Director of Sales, Regional Vice President and most recently as National Business Director for Quintiles, and has managed and led sales teams ranging from 90 to 450 salespeople. He is a consummate leader in the pharmaceutical industry.

Mr. Pasek started his pharmaceutical career with GSK, where he helped build and lead the dermatology division and established GSK as the most admired company in that therapeutic category. During his time at GSK, he launched 11 brands in the dermatology market. In 2002, he joined Sepracor, which later became Sunovion.

He was a founding member of the Sepracor commercial team and was instrumental in deciding the overall size and structure of the Sepracor sales team. During this time, he helped the organization grow from $200M in sales to $1.4B. He played a significant role in the launch strategy and execution of Lunesta – one of the top 10 pharmaceutical launches at the time.

Mr. Pasek has a degree in Business Economics from the University of Southern Connecticut.

Richard V. Myer

Vice President, Business Development, North America

Richard V. Myer has over 20 years' experience within the pharmaceutical services industries focused on business development management positions.

Since joining Avara's Corporate Commercial Team in 2016 Rich has been instrumental in building and managing the North American business development team. In his position he has successfully identified and won new business opportunities for our global facilities as he continues to grow the North American business development team. Rich's team now has four business development directors, whom, along with Rich are focused on North America and responsible for driving new business to our global facilities.

Prior to Avara, Rich held business development management positions with contract service providers, including, AAI, MDS and Xcelience enabling him to develop expertise across the drug development continuum while managing teams for the last 15 years. Rich began his career conducting molecular biology research at Rush-Presbyterian-St. Luke's Medical Center in Chicago, IL.

Rich holds a BA as well as an MBA from Purdue University.

Russell B. Harris

Vice President, Business Development, Europe

Russell Harris has 20+ years of experience in the pharmaceutical industry with senior roles in Manufacturing, Procurement and Business Development with major pharmaceutical companies. In addition, he has gained extensive experience in Pharmaceutical B2B third party sales and is a proven leader capable of driving robust and innovative sourcing and selling approaches for global markets.

Since joining Avara’s Corporate Commercial Team in January 2017, Russell has been part of the Business Development team driving new project opportunities to our global facilities that would utilize our manufacturing capabilities for oral solid dose and sterile fill and finish drug products. Russell is currently VP of Business Development based in London.

Russell began his career working in manufacturing for Glaxo-Wellcome. In 2000, he moved into a procurement role sourcing contract manufacturing services for GSK. In 2004, he moved to Abbott Laboratories in a Director role responsible for sourcing indirect and direct services. In 2011, he returned to GSK as the Business Development Director, promoting manufacturing capacity from GSK’s global footprint.

Russell holds a BA (with honors) from The University of Kent, UK.

Lindsay Caithness, Ph.D.

Vice President of Network Planning

Dr. Lindsay Caithness has 22 years of experience in the pharmaceutical industry with roles in Research & Development, Projects and Proposals Management, Pharmaceutical Development and Manufacturing and in Clinical Services and Supply Management.

Since joining Avara's Corporate Commercial Team in mid-2018, Lindsay has been responsible for optimizing Avara's global processes and systems across customer service and with proposal submissions to our customers. In addition, she has been working with our site project teams to improve our project management functions and site operating reviews across our global facilities.

Lindsay held global leadership positions at Catalent Pharma Solutions and Aptuit CDMOs, leading global Project and Proposals Management. Lindsay began her pharmaceutical career with Dabur Oncology, a start-up cytotoxin manufacturing facility, now owned by Fresenius Kabi, before moving to Fisher Clinical Services as a Project Manager, leading global clinical manufacturing and supply projects for Clients.

Lindsay has a BSc in Biochemistry from The University of St Andrews, UK, and a PhD in Molecular Toxicology and Pharmacology from The University of Surrey, UK.

Pam Maguire

Vice President, Human Resources

Pam Maguire began her career in Human Resources for a financial retail chain as Director of HR and Marketing. After the divesture of the organization she was recruited by the company’s health insurance broker and spent several years as a licensed health insurance agent serving the benefits needs of small to medium sized employers. She went to work in the Human Resources Department at a pharmaceutical manufacturing facility and has spent the last 18 years in pharmaceutical manufacturing. Pam has extensive experience in human resources, compensation, benefits, workforce development and training. She is responsible for spearheading consistency across the Avara business units in compensation, benefits, workforce best practices and internal communications platforms.

Pam is a graduate of the University of Oklahoma and is PHR and SHRM-CP certified. She is committed to making sure employees are educated in all aspects of their compensation, benefits, and company resources. Her core commitment is to provide a strong foundation to talent, so the manufacturing sector can compete and offer quality products to our customers. She is a member of SHRM and ASIS. Pam is certified to train in various programs including the Speed of Trust and the change management curriculum, Our Iceberg is Melting. Pam holds a Masters of HR Management from Villanova University.

Pam resides in Norman, Oklahoma where she has spent years caring for her family, building a career, and contributing to the community. She has been involved in many community support organizations including the United Way Board of Directors, Jr. Achievement, The Maguire Foundation, and The Sooner Human Resources Society Board and the Central Oklahoma Workforce Investment Board (COWIB).

Mohan R. Gajjala

Vice President, Information Technology

Mohan R. Gajjala is a proven Global Pharmaceutical and Biotechnology leader with more than 29 years of leadership and technology experience. Mohan has a successful record of developing and leading global organizations, achieving strategic objectives, talent development and delivering tangible business results in pharmaceutical, technology, automotive and engineering industries.

Mohan is accomplished at helping IT departments become a value proposition for their organizations. In a career defined by collaboration and results, Mohan is both a turnaround architect of the highest order and someone able to grow and develop an entire IT organization.

Recently, Mohan has led the development of IT strategies for Multiple supply chains of GlaxoSmithKline Pharmaceuticals and Medimmune (AstraZeneca). This includes global ERP, supply chain, commercial, business and regulated environments coupled with a vendor partnership operating model.
Mohan joined Avara Pharmaceutical Services in January 2019.

Mohan holds a bachelor's degree in Mechanical Engineering from University of Mysore, India.

Ronald Small MBA, BS Pharm, ScD (Hon), FAPhA, FASHP, CEC

Advisor

Ronald Small’s experience is unique as he has held executive positions in healthcare organizations and has served as an Executive Strategic Advisor to c-suite leaders in Hospitals and Health Systems, Group Buying Organizations (GPOs), The Joint Commission, Pharmacy Professional Organizations and the Pharmaceutical Industry.

Career Highlights include:

  • Board of Trustees for American Pharmaceutical Association
  • Vice-President, Quality, Safety and Service Excellence and Chief Pharmacy Officer at Wake Forest University Baptist Health for approximately 37 years.
  • Interim CIO for the Medical Center's Informatics Center and for two years as Chief Procurement Officer.
  • Consultant for 5 years with the Joint Commission Resources and Joint Commission International.
  • Contributed to the professional body of knowledge on such topics as quality leadership and quality improvement, Lean Six Sigma, antimicrobial utilization stewardship, drug cost reduction strategies, the safe adoption of technologies in the medication use process and quality of care improvement strategies.
  • Invited speaker in the US and internationally addressing patient safety, leadership for quality improvement, and issues related to improving IV medication practices.

E. Paul Larrat

Advisor

Paul Larrat is Dean and Professor at The University of Rhode Island College of Pharmacy. His research and teaching efforts have focused on drug use in special populations, health policy, and health economics issues. He also served as the Founding Coordinating Dean of URI's Academic Health Collaborative from 2015-19 and Executive Secretary of the RI Crime Laboratory Commission.

Earlier in his career, Paul was employed as Executive Vice President of MIM Health Plans [now Bioscript : BIOS] where he was responsible for the developing the operations of this pharmacy benefit management company. He oversaw the growth of the company from $3 million in gross revenues in 1994 to over $300 million in 1997. His responsibilities there included oversight of clinical services, provider network development, manufacturer contracting, disease state management, quality assurance, provider auditing and credentialing. Paul is a past president of several not-for-profit organizations, including the Rhode Island Pharmacists Association, the Rhode Island Pharmacy Foundation and Cornerstone Adult Services. He has been a leader in organizing several more non-profits, including the RI chapter of the Alzheimer's Association and the Mwea Fund, which assists in advancing health and education in a primary school district in Thika, Kenya.

A graduate of The University of Rhode Island with a Bachelor of Science in Pharmacy in 1982, Paul received a Master of Business Administration in 1984 and Master of Science in Pharmacy Administration in 1988. Most recently he was awarded a Ph. D. in epidemiology from Brown University. In 2004, he was named a NASA Fellow and spent several months at Kennedy Space Center assisting in life sciences research projects focusing on volatile organic compound production during extended space travel. In 2010-11, he served as AAAS/AACP Congressional Health Policy Fellow in the United States Senate, engaged in developing health care and aging legislation and policy in the office of Finance Committee Chair Sen. Ron Wyden (OR-D).

Paul has been married to Amey Larrat for over 30 years and has two grown children, Meghan and Eric. He is an avid outdoorsman, spending time mountaineering, white water canoeing and sailing. His favorite climbs have been Mt. Rainier in Washington and Mt. Kilimanjaro in Tanzania, and he has reached his goal of climbing the 48 high points of the continental US with his son, Eric.

Andrea Baiocchi

Vice President and Site Director, Liscate Italy

Andrea Baiocchi is a proven leader with over 20 years of experience in the pharmaceutical industry. Andrea began his career with Pfizer in 1997 at the former Pharmacia & Upjohn headquarters in Milan Italy as a Business Control Analyst and moved to the Ascoli Italy site in 1998.

As the Director of Finance in 2001 Andrea drove the integration of Pharmacia into Pfizer as a team member and team leader. In 2006, Andrea was appointed Finance Director for the Ascoli and Nerviano, Italy sites and in February 2008, he was appointed Director, Materials Management at the Ascoli Italy site.

In September 2015, Andrea assumed the role of Site Integration Leader for Liscate Italy as part of the Pfizer acquisition of Hospira Inc. In December 2016 he was named Site Leader of the Liscate Italy, Sterile Injectable site and appointed to drive the site transition out of the Pfizer Network which concluded with the site sale to Avara Pharmaceutical Services in September 2017.

In December 2017 Andrea joined Avara Pharmaceutical Services as The VP & Site Director for the Liscate, Italy Sterile injectable site. Under his guidance and with the dedication of his leadership team they have successfully transition the activities of the site to a Contract Manufacturing Organization (CMO).

Andrea is Certified in Production and Inventory Management (CPIM) and a Certified Supply Chain Professional (CSCP).

Andrea has a degree in Business Economics from the Politecnico delle Marche Institute and an M.B.A. in Business Management from ISTAO - Istituto Adriano Olivetti, Ancona / Italy.

Idalia M. Garcia

Vice President and Site Director, Arecibo Puerto Rico

Idalia M. Garcia has over 24 years of experience in the pharmaceutical industry with leadership roles in Technical Operations, Quality Operations and Production Management. Her experience has provided a comprehensive understanding of pharmaceutical solid dosage forms manufacturing as well as the technical, regulatory and business aspects required to achieve success for the site and the Arecibo customers.

Idalia began her career with Eli Lilly as Process Scientist working on technical transfers before moving to Merck as Process Scientist in Technical roles. Idalia held site and regional leadership roles at Merck, as the Technical Director, Quality Director - External Partners and ultimately Operations Director, Latin America.

Idalia has successfully achieved business results and implemented organizational changes while providing development opportunities to site leadership and their team members. She has demonstrated success in achieving customer/patient goals through multiple interactions with suppliers, customers and regulatory authorities.

Idalia had led the Arecibo site through the divestiture process from Merck to Avara in 2015, prior to assuming the Site VP role at Arecibo for Avara. Since joining Avara in 2015, Idalia has been leading the Arecibo site through the transition to a CMO business model while maintaining continuity of supply to our customers.

Idalia has a BSc in Pharmacy and MSc in Industrial Pharmacy from University of Puerto Rico.

Tim D. Fogle

Vice President, Finance, North America

Tim Fogle has 20+ years of experience in the pharmaceutical and manufacturing industries with senior roles in cost accounting as well as managerial roles in accounting and finance. Tim is an accomplished leader with vast experience in all aspects of accounting, financial reporting, budgeting and planning, system implementation, and internal controls. In addition, Tim has utilized his In-depth knowledge of applying Generally Accepted Accounting Principles (GAAP) in a manufacturing setting, to successfully accomplish outstanding audit results.

Tim began his career in cost accounting working in the energy services and IT space. The last 15 years he has held roles in the pharmaceutical manufacturing space as a cost accountant, accounting manager and controller for the Norman facility. Since joining Avara’s Corporate Finance Team in August 2016, Tim has been responsible for accounting and financial reporting across multiple sites in the Avara network. Our facilities manufacture oral solid dose and sterile fill and finish drug products. Tim has held roles with increasing responsibilities and was appointed to his current role of VP, Finance NA in April 2019. Tim is based at our Corporate Headquarters in Norman, Oklahoma.

Tim holds a Bachelor of Business Administration in Accounting from Oklahoma City University and a Master of Business Administration (MBA) from University of Oklahoma. In addition, Tim holds a Certified Managerial Accountant License (CMA).

Patrick D. Hatem

Vice President and Site Director, Aiken South Carolina

Patrick D. Hatem has 27 years of industry experience including 20 years in management roles with progressively increasing responsibilities in contract manufacturing organizations as well as specialty pharmaceutical companies. Through his experience he has established a foundation of development, analytical, quality/regulatory, manufacturing and supply chain expertise which allowed him to successfully lead new product launches in the North America, South America and Europe as both a submission sponsor and as a submission partner.

Joining Avara in August 2019, Patrick is the VP and Site Director for our Aiken South Carolina manufacturing facility. With his experience as both a contract provider and contract manager he will leverage this perspective to drive world class customer service meeting the needs of Avara’s customers.

Patrick began his career with Roxane Laboratories, ICN Pharmaceuticals and AAI Pharmaceuticals with roles in Product Development, Analytical Development, Quality Control, Validation, Technical Services and Manufacturing. In 2006 he joined Osmotica Pharmaceuticals to lead the management of their contract manufacturers and supply chain. Prior to Avara Patrick was the VP Manufacturing at UPM Pharmaceuticals building on their foundation of strong early phase development in Baltimore, MD to a largescale commercial supplier in Bristol, TN. Driving UPM’s growth with a combination of site legacy products, contract development products and direct site transfers.

Patrick holds a Bachelor of Science degree in Biology from Ohio Dominican University in Columbus, OH.

Agnès Pierson

General Manager, Site Lead and Deputy Head Pharmacist, Reims France

Agnès Pierson has more than 30 years of experience in the pharmaceutical industry, with roles in Quality Control, Production, Oral Solid Dose (OSD) manufacturing and packaging, Project Management, Distribution, Quality Assurance and Site Leadership, all in a Production Plant environment.

Since 2017, Agnès has served as the Site Leader for Avara's Reims, France facility. During that time, she successfully led Reims site transformation from a legacy pharma production facility to a distribution and packaging facility as a Contract Manufacturing Organization (CMO) for Avara Pharmaceutical Services.

Agnes is certified as a Head Pharmacist (HP) according to French legislation, as well as Qualified Person (QP) according to European legislation.

Agnès holds a Degree in Pharmacy from Reims University, France.

Flor D. Rivera Davila

Assistant Vice President Quality Assurance / Regulatory Affairs, North America

Flor D. Rivera Davila has more than 22 years of experience in the pharmaceutical industry in Plant Management and Operations roles along with a strong focus on quality and compliance.

For the past two years, Flor has served as the Director, Quality for Avara's Arecibo site. During that time, she oversaw the site's successful re-start following Hurricanes Irma and Maria, including managing the site's quality actions completion and documentation.

Flor holds a Bachelor of Science in Biology from the University of Puerto Rico, Rio Piedras Campus and holds an MT certification from the Puerto Rico Department of Health and the American Association of Clinical Pathologists.

Luca Varesi

Interim Assistant Vice President Quality Assurance / Regulatory Affairs, Europe

Luca Varesi has more than 25 years of experience in the pharmaceutical industry, initially with roles in research and development and subsequently holding different roles in Quality Assurance, both in a Production Plant and a Corporate environment, with a strong focus on sterile products.

For the past year and a half, Luca has served as the Leader, Quality Assurance for Avara's Liscate, Italy site. During that time, he successfully defined and implemented QA standards and strategies for the site, while maintaining compliance with EU regulations and company policies.

Luca holds a Degree in Pharmacy from Milan University, and is certified as a Qualified Person (QP) according to European legislation, as well as a professional Pharmacist.